Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, reported preclinical data this week at the Association for Research in ...

If it's your first time using a retinoid, look for retinol creams with ingredients like hyaluronic acid, squalane and ...

Pham, who’s accused of violating the Federal Food, Drug, and Cosmetic Act, has pleaded guilty to a federal charge: receipt in ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...

In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...

In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined ...

New research reveals that hypoglycemia may worsen diabetic retinopathy by breaking down the blood-retinal barrier.

Jiarui Nie, a postdoctoral researcher at the National Institutes of Health, is exploring how gold nanoparticles injected into ...

Pykus Therapeutics, Inc. ("Pykus" or the "Company") today announced the presentation of positive clinical data from of its ...

A study reveals that repeated anti-VEGF injections for AMD do not alter retinal vascular metrics over time, ensuring ...

At the ARVO 2025 meeting in Salt Lake City, Utah, Cameron Cummings presented a poster on how retinal microvascular imaging ...

Lower socioeconomic status was linked with worse eye structure and function at initial presentation in patients undergoing ...